Recurrent supraventricular tachycardia in a newborn treated with amiodarone: is hyperkalemia the apparent cause?

Supraventricular tachycardia (SVT) is the most common type of arrhythmia observed in children, especially in newborns. Infants with severe SVT must be treated immediately with first-line drugs such as amiodarone. There are some minor and major side effects of amiodarone in this patient group, but no...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric cardiology 2005-12, Vol.26 (6), p.879-880
Main Authors: Yildirim, S V, Tiker, F, Cengiz, N, Kiliçdağ, H
Format: Article
Language:English
Subjects:
Amiodarone - therapeutic use
Anti-Arrhythmia Agents - therapeutic use
Arrhythmia
Case studies
Children
Health aspects
Humans
Hyperkalemia - complications
Infant, Newborn
Male
Secondary Prevention
Supraventricular tachycardia
Tachycardia, Supraventricular - drug therapy
Tachycardia, Supraventricular - etiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Supraventricular tachycardia (SVT) is the most common type of arrhythmia observed in children, especially in newborns. Infants with severe SVT must be treated immediately with first-line drugs such as amiodarone. There are some minor and major side effects of amiodarone in this patient group, but no associated electrolyte disorders have been observed. This report describes a newborn whose recurrent SVT attacks during amiodarone treatment were suspected to have been caused by hyperkalemia.
ISSN:0172-0643
1432-1971
DOI:10.1007/s00246-005-1043-z